$13.89
+1.06 (+8.26%)
Open$13.04
Previous Close$12.83
Day High$14.08
Day Low$13.03
52W High$19.11
52W Low$9.51
Volume—
Avg Volume1.90M
Market Cap1.21B
P/E Ratio—
EPS$-3.50
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
-33.7% upside
Current
$13.89
$13.89
Target
$9.21
$9.21
$6.71
$9.21 avg
$14.14
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 37.84M | 41.51M | 211.34M |
| Net Income | -279,803,213 | -276,212,451 | 52.60M |
| Profit Margin | -739.4% | -702.5% | 24.9% |
| EBITDA | -290,856,796 | -303,075,525 | 60.54M |
| Free Cash Flow | — | — | 38.74M |
| Rev Growth | -8.8% | -8.8% | -6.2% |
| Debt/Equity | — | — | 0.26 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |